Value of 2 IgG avidity commercial tests used alone or in association to date toxoplasmosis contamination

Diagnostic Microbiology and Infectious Disease

Volumn 64, Issue 3, 2009, Pages 267-274

  Lachaud, Laurence ^a   Calas, Olivier ^b   Picot, Marie Christine ^b   Albaba, Sahar ^b   Bourgeois, Nathalie ^a   Pratlong, Francine ^a  

^a UNIV MONTPELLIER   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

Avidity tests; Comparison; Pregnant women; Toxoplasmosis

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNOCOMPROMISED PATIENT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NEWBORN; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANTIBODY AFFINITY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT, NEWBORN; PREGNANCY; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOXOPLASMOSIS;

EID: 67349176627     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.02.014     Document Type: Article

References (31)

1. Ajzenberg D., Bañuls A.L., Su C., Dumetre A., Demar M., Carme B., and Dardé M.L. Genetic diversity, clonality and sexuality in Toxoplasma gondii. Int. J. Parasitol. 34 (2004) 1185-1196
2. Alvarado-Esquivel C., Sethi S., Janitschke K., Hahn H., and Liesenfeld O. Comparison of two commercially available avidity tests for Toxoplasma-specific IgG antibodies. Arch. Med. Res. 33 (2002) 520-523
3. Ashburn D., Joss A.W.L., Pennington T.H., and Ho-Yen D.O. Do IgA, IgE, and IgG avidity tests have any value in the diagnosis of Toxoplasma infection in pregnancy?. J. Clin. Pathol. 51 (1998) 312-315
4. Barberi A., Gistri A., Cappelletti F., and Giordano I. Diagnostic value of IgG avidity in Toxoplasma infection : comparison of 3 commercial Kits. J. Infect. Dis. 184 (2001) 944-945
5. Berger F., Goulet V., Le Strat Y., and Désenclos J.C. Toxoplasmose chez les femmes enceintes en France: évolution de la séroprévalence et de l'incidence et facteurs associés, 1995-2003. BEH Thématique. 14-15 (2008) 117-121
6. Buffolano W., Lappalainen M., Hedman L., Ciccimarra F., Del Pezzo M., Rescaldani R., Gargajo N., and Hedman K. Delayed maturation of IgG avidity in congenital toxoplasmosis. Eur. J. Clin. Microbiol. Infect. Dis. 23 (2004) 825-830
7. Candolfi E., Pastor R., Huber R., Filisetti D., and Villard O. IgG avidity assay firms up the diagnosis of acute toxoplasmosis on the first serum sample in immunocompetent pregnant women. Diagn. Microbiol. Infect. Dis. 58 (2007) 83-88
8. Carme B., Bissuel F., Ajzenberg D., Bouyne R., Aznar C., Demar M., Louvel D., Bourbigot A.M., Peneau C., Neron P., and Dardé M.L. Severe acquired toxoplasmosis in immunocompetent adult patients in French Guiana. J. Clin. Microbiol. 40 (2002) 4037-4044
9. Cozon G.J.N., Ferrandiz J., Nebhi H., Wallon M., and Peyron F. Estimation of the avidity of immunoglobulin G for routine diagnosis of chronic Toxoplasma gondii infection in pregnant women. Eur. J. Clin. Microbiol. Infect. Dis. 17 (1998) 32-36
10. Eloy O., Ould Mohamed A.E., Zuilly E., Volland J., and Ghnassia J.C. Exclusion d'infection toxoplasmique récente chez la femme enceinte par la méthode Toxo IgG avidity Vidas. Ann. Biol. Clin. 58 (2000) 194-197
11. Flori P., Bellete B., Crampe C., Maudry A., Patural H., Chauleur C., Hafid J., Raberin H., and Tran Manh Sung R. A technique for dating toxoplasmosis in pregnancy and comparison with the Vidas anti-toxoplasma IgG avidity test. Clin. Microbiol. Infect. 14 (2008) 242-249
12. Fricker-Hidalgo H., Saddoux C., Suchel-Jambon A.S., Romand S., Foussadier A., Pelloux H., and Thulliez P. New Vidas assay for Toxoplasma-specific IgG avidity: evaluation on 603 sera. Diagn. Microbiol. Infect. Dis. 56 (2006) 167-172
13. Gutiérrez J., Rodriguez M., Piédrola G., and del Carmen Maroto M. Detection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis. Clin. Microbiol. Infect. 3 (1997) 658-662
14. Hedman K., Lappalainen M., and Seppäiä I. Recent primary Toxoplasma infection indicated by a low avidity of specific IgG. J. Infect. Dis. 159 (1989) 736-740
15. Horváth K.H., Szénási Z., Danka J., and Kucsera I. Value of the IgG avidity in the diagnosis of recent toxoplasmosis: a comparative study of four commercially available anti-Toxoplasma gondii IgG avidity assays. Acta Parasitologica. 50 (2005) 255-260
16. Jenum P.A., Stray-Pedersen B., and Gundersen A.G. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J. Clin. Microbiol. 35 (1997) 1972-1977
17. Joynson D.H.M., Payne R.A., and Rawal B.K. Potential role of IgG avidity for diagnosing toxoplasmosis. J. Clin. Pathol. 43 (1990) 1032-1033
18. Lappalainen M., and Hedman K. Serodiagnosis of toxoplasmosis. The impact of measurement of IgG avidity. Ann. Ist. Super. Sanità. 40 (2004) 81-88
19. Lappalainen M., Koskela P., Koskiniemi M., Ämmälä P., Hiilesmaa V., Teramo K., Raivio K.O., Remington J., and Hedman K. Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. J. Infect. Dis. 167 (1993) 691-697
20. Lecolier B., and Pucheu B. Intérêt de l'étude de l'avidité des IgG pour le diagnostic de la toxoplasmose. Path. Biol. 41 (1993) 155-158
21. Lecolier B., and Pucheu B. Comparaison de deux techniques de mesure de l'avidité des Ig G pour le diagnostic de la toxoplasmose. Rev. fr. lab. 271 (1994) 15-18
22. Lefevre-Pettazzoni M., Le Cam S., Wallon M., and Peyron F. Delayed maturation of immunoglobulin G avidity: implication for the diagnosis of toxoplasmosis in pregnant women. Eur. J. Clin. Microbiol. Infect. Dis. 25 (2006) 687-693
23. Liesenfeld O., Montoya J.G., Kinney S., Press C., and Remington J.S. Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. J. Infect. Dis. 183 (2001) 1248-1253
24. Mechain B., Garin Y.J.F., Robert-Gangneux F., Dupouy-Camet J., and Derouin F. Lack of utility of specific immunoglobulin G antibody avidity for serodiagnosis of reactivated toxoplasmosis in immunocompromised patients. Clin. Diagn. Lab. Immunol. 7 (2000) 703-705
25. Montoya J.G., Liesenfeld O., Kinney S., Press C., and Remington J.S. VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women. J. Clin. Microbiol. 40 (2002) 2504-2508
26. Pelloux H., Brun E., Vernet G., Marcillat S., Jolivet M., Guergour D., Fricker-Hidalgo H., Goullier-Fleuret A., and Ambroise-Thomas P. Determination of anti- Toxoplasma gondii immunoglobulin G avidity: adaptation to the Vidas system (bioMérieux). Diagn. Microbiol. Infect. Dis. 32 (1998) 69-73
27. Petersen E., Borobio M.V., Guy E., Liesenfeld O., Meroni V., Naessens A., Spranzi E., and Thulliez P. European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index. J. Clin. Microbiol. 43 (2005) 1570-1574
28. Press C., Montoya J.G., and Remington J.S. Use of a single serum for diagnosis of acute toxoplasmosis in pregnant women and other adults. J. Clin. Microbiol. 43 (2005) 3481-3483
29. Remington J.S., McLeod R., Thulliez P., and Desmonts G. Toxoplasmosis. In: Remington J.S., and Klein J. (Eds). Infectious diseases of the fetus and newborn infant, 5th edn (2001), WB Saunders, Philadelphia 205-346
30. Roberts A., Hedman K., Luyasu V., Zufferey J., Bessières M.H., Blatz R.M., Candolfi E., Decoster A., Enders G., Gross U., Guy E., Hayde M., Ho-Yen D., Johnson J., Lécolier B., Naessens A., Pelloux H., Thulliez P., and Petersen E. Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur. J. Clin. Microbiol. Infect. Dis. 20 (2001) 467-474
31. Sensini A., Pascoli S., Marchetti D., Castronari R., Marangi M., Sbaraglia G., Cimmino C., Favero A., Castelleto M., and Mottola A. IgG avidity in the serodiagnosis of acute Toxoplasma gondii infection: a multicenter study. Clin. Microbiol. Infect. 2 (1996) 25-29